Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & CEO, Director
-
Stock Symbol
-
RARE on Nasdaq
Emil D. Kakkis - trading volume in the past year for Ultragenyx Pharmaceutical Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
2.22M |
$124M |
$55.85 |
Sep 3, 2024 |
See FN |
|
|
| Common Stock |
565K |
$31.5M |
$55.85 |
Sep 3, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
70.1K |
|
|
Mar 1, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.